- Aripiprazole
- Aripiprazole-d8 (butyl-d8)
- 129722-25-42(1H)-Quinolinone,7-[4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butoxy]-
- 129722-34-52(1H)-Quinolinone,7-(4-bromobutoxy)-3,4-dihydro-
- 129724-43-22-Propen-1-one,1-(2,4-dihydroxy-3,6-dimethoxyphenyl)-3-phenyl-, (2E)-
- 129724-83-0Lanosta-9(11),24-dien-26-oicacid, 3-hydroxy-, (3b,24Z)- (9CI)
- 129725-48-03-(1-aminoethyl)phenylamine
- 129728-87-6a-D-Glucopyranose,2-(acetylamino)-2,4-dideoxy-4-fluoro-
- 129735-00-8Adenosine, 8-bromo-,cyclic 3',5'-[hydrogen [P(R)]-phosphorothioate] (9CI)
- 129735-01-9Adenosine,8-[(4-chlorophenyl)thio]-, cyclic 3',5'-[hydrogen (R)-phosphorothioate] (9CI)
- 129-73-7Benzenamine,4,4'-(phenylmethylene)bis[N,N-dimethyl-
- 129738-34-71,1'-Bicyclohexyl,4-ethenyl-4'-pentyl-, (trans,trans)-
Hot Products
- 99300-78-4Venlafaxine hydrochloride
- 112529-15-4Pioglitazone hydrochloride
- 51481-61-9Cimetidine
- 231277-92-2Lapatinib
- 75330-75-5Butanoic acid, 2-methyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester, (2S)-
- 71-00-1L-Histidine
- 169590-42-5Celecoxib
- 87333-19-5Ramipril
- 104987-11-3Tacrolimus
- 141-53-7Sodium formate
- 8001-54-5Quaternary ammonium compounds, alkylbenzyldimethyl, chlorides
- 9003-39-8Povidone
- 10161-34-9Trenbolone acetate
- 402957-28-2Telaprevir
- 68-19-9Cyanocobalamin
|
Basic Information |
|
Post buying leads |
|
Suppliers |
|
Cas Database |
| Name |
Aripiprazole |
EINECS | 200-835-2 |
| CAS No. | 129722-12-9 | Density | 1.263 g/cm3 |
| PSA | 44.81000 | LogP | 5.00020 |
| Solubility | N/A | Melting Point |
139 °C |
| Formula | C23H27Cl2N3O2 | Boiling Point | 646.2 °C at 760 mmHg |
| Molecular Weight | 448.392 | Flash Point | 344.6 °C |
| Transport Information | N/A | Appearance | colourless flake crystalline solid |
| Safety | 16-36/37 | Risk Codes | 11-20/21/22-36 |
| Molecular Structure |
|
Hazard Symbols | F,Xn |
| Synonyms |
Aripiprazole [USAN];Aripiprazole (JAN/USAN);2(1H)-Quinolinone,7-[4-[4-(2,3-dichlorophenyl)- 1-piperazinyl]butoxy]-3,4-dihydro-;7-(4-(4-(2,3-Dichlorophenyl)-1-piperazinyl)butoxy)-3,4-dihydro-2(1H)-quinolinone;Abilitat;7-(4-(4-(2,3-Dichlorophenyl)-1-piperazinyl)butyloxy)-3,4-dihydro-2(1H)-quinolinone;OPC-14597;Abilify (TN);Abilify;7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-3,4-dihydro-1H-quinolin-2-one;OPC 31;2(1H)-Quinolinone, 7-(4-(4-(2,3-dichlorophenyl)-1-piperazinyl)butoxy)-3,4-dihydro-;Opc 14597;Arpiprazole;Alipiprazole;Aripiprzole;Aripipazole;7-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one; |
Article Data | 62 |
Aripiprazole Synthetic route
- 1026778-41-5
Aripiprazole hydrochloride
- 129722-12-9
aripiprazole
| Conditions | Yield |
|---|---|
| at 100 - 120℃; for 21h; Industrial scale; | 99.3% |
| With sodium hydroxide; water In isopropyl alcohol at 15 - 80℃; for 4.5h; pH=>= 12; | |
| With sodium hydroxide In methanol; water at 20 - 45℃; |
- 120004-79-7
3,4-dihydro-7-(4-chlorobutoxy)-2(1H)-quinolinone
- 129722-12-9
aripiprazole
| Conditions | Yield |
|---|---|
| With potassium carbonate In water for 3h; Reflux; | 98% |
| With potassium carbonate In water for 3h; Reflux; | 98% |
| With potassium carbonate In water at 90 - 95℃; for 4h; | 92.8% |
- 884596-21-8
7-[4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butoxy]-3,4-dihydro-2(1H)-quinolinone methanol solvate
- 129722-12-9
aripiprazole
| Conditions | Yield |
|---|---|
| In isopropyl alcohol Product distribution / selectivity; | 96.8% |
| In acetonitrile for 2h; Product distribution / selectivity; Heating / reflux; | 91.4% |
| In Isopropyl acetate for 2h; Product distribution / selectivity; Heating / reflux; | 85.7% |
- 129722-12-9
aripiprazole
| Conditions | Yield |
|---|---|
| In isopropyl alcohol Product distribution / selectivity; | 94.6% |
| In ethyl acetate Product distribution / selectivity; Heating / reflux; | |
| at 90℃; for 6h; Product distribution / selectivity; | |
| at 80℃; for 15h; Product distribution / selectivity; |
- 120004-79-7
3,4-dihydro-7-(4-chlorobutoxy)-2(1H)-quinolinone
- 41202-77-1
1-(2,3-dichlorophenyl)piperazine
- 129722-12-9
aripiprazole
| Conditions | Yield |
|---|---|
| Stage #1: 7-(4-chlorobutoxy)-3,4-dihydroquinolin-2(1H)-one With sodium iodide In N,N-dimethyl-formamide at 70 - 80℃; for 1h; Stage #2: 1-(2,3-dichlorophenyl)piperazine With potassium carbonate In N,N-dimethyl-formamide at 70 - 80℃; for 4h; | 94% |
| With potassium carbonate In N,N-dimethyl-formamide at 100℃; | 57 mg |
- 201230-82-2
carbon monoxide
- 129722-12-9
aripiprazole
| Conditions | Yield |
|---|---|
| With palladium (II) nitrate; 2,2'-bis-(diphenylphosphino)-1,1'-binaphthyl In tetrahydrofuran; water at 50℃; under 30003 Torr; for 20h; Pressure; Temperature; Reagent/catalyst; | 94% |
| With palladium(II) trifluoroacetate; toluene-4-sulfonic acid In tetrahydrofuran at 80℃; under 26601.8 Torr; for 20h; regioselective reaction; | 1.074 g |
- 851220-85-4
aripiprazole monohydrate
- 129722-12-9
aripiprazole
| Conditions | Yield |
|---|---|
| In isopropyl alcohol Product distribution / selectivity; | 93.6% |
| at 60 - 125℃; for 1 - 50h; Conversion of starting material; |
- 129722-12-9
aripiprazole
| Conditions | Yield |
|---|---|
| With ammonia; water In chloroform at 30 - 35℃; for 0.333333h; Product distribution / selectivity; | 93.43% |
| Conditions | Yield |
|---|---|
| With potassium carbonate In water at 99℃; for 5h; Reagent/catalyst; Temperature; | 91.4% |
- 1258382-04-5
7-(4-(4-(2,3-dichlorophenyl)-1-piperazinyl)-butoxy)-3,4-dihydro-2(1H)-carbostyril maleate
- 129722-12-9
aripiprazole
| Conditions | Yield |
|---|---|
| With sodium hydroxide In water; toluene at 65℃; for 0.25h; pH=~ 11; Product distribution / selectivity; | 91% |
| With sodium hydroxide In water; toluene at 65 - 80℃; for 0.5h; pH=~ 11; | 91% |
Aripiprazole Chemical Properties
Molecular structure of Aripiprazole (CAS NO.129722-12-9) is:
Product Name: Aripiprazole
CAS Registry Number: 129722-12-9
IUPAC Name: 7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-3,4-dihydro-1H-quinolin-2-one
Molecular Weight: 448.38538 [g/mol]
Molecular Formula: C23H27Cl2N3O2
XLogP3-AA: 4.6
H-Bond Donor: 1
H-Bond Acceptor: 4
Melting Point: 139 °C
Surface Tension: 48.4 dyne/cm
Density: 1.263 g/cm3
Flash Point: 344.6 °C
Enthalpy of Vaporization: 95.31 kJ/mol
Boiling Point: 646.2 °C at 760 mmHg
Vapour Pressure: 1.38E-16 mmHg at 25°C
Product Categories: Inorganic & Organic chemicals;Active Pharmaceutical Ingredients;API;Heterocyclic Compounds;Chemistry;Intermediates & Fine Chemicals;Neurochemicals;Pharmaceuticals;Isotope Labeled Compounds
Aripiprazole History
Aripiprazole (CAS NO.129722-12-9) was approved by the Food and Drug Administration on November 15, 2002 for the treatment of schizophrenia, the sixth atypical antipsychotic medication of its kind. More recently, it received FDA approval for the treatment of acute manic and mixed episodes associated with bipolar disorder, and as an adjunct for the treatment of major depressive disorder.It was developed by Otsuka in Japan; in the U.S., Otsuka America markets the drug jointly with Bristol-Myers Squibb.
Aripiprazole Uses
Aripiprazole (CAS NO.129722-12-9) is used for the treatment of schizophrenia, the sixth atypical antipsychotic medication of its kind and for the treatment of acute manic and mixed episodes, in both pediatric patients aged 10–17 and in adults. Also it is used as an adjunct for the treatment of major depressive disorder. It has been approved by the FDA for the treatment of schizophrenia and for the treatment of unipolar depression when used adjunctively with an antidepressant medication.Also, it can treat irritability in persons with autism.
Aripiprazole Specification
What can I do for you?
Get Best Price
